TAGRISSO reduces disease progression or death by 84 % in Stage III EGFR-mutated lung cancer vs.…
First and only EGFR inhibitor and targeted treatment to show benefit in stage III setting, extending progression-free survival…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.